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Background: This systematic review is an evaluation of the empirical literature relating to the disordered eating
behaviour Chew and Spit (CHSP). Current theories postulate that CHSP is a symptom exhibited by individuals with
recurrent binge eating and Bulimia Nervosa.
Aims: The review aimed to identify and critically assess studies that have examined the distribution of CHSP
behaviour, its relationship to eating disorders, its physical and psychosocial consequences and treatment.
Methods: A systematic database search with broad inclusion criteria, dated to January 2016 was conducted. Data
were extracted by two authors and papers appraised for quality using a modified Downs and Black Quality Index.
Results: Nine studies met the inclusion criteria. All were of clinical samples and majority (n = 7) were of low quality.
The pathological action of chewing food but not swallowing was reported more often in those with restrictive type
eating disorders, such as Anorexia Nervosa, than binge eating type disorders. CHSP also was reported to be an
indicator of overall severity of an eating disorder and to appear more often in younger individuals. No studies of
treatment were found.
Conclusions: Conclusions were limited due to the low quality and small numbers of studies based on clinical
samples only. Further research is needed to address gaps in knowledge regarding the physiological, psychological,
social, socioeconomic impact and treatment for those engaging in CHSP.
Keywords: Chew and Spit, CHSP, Oral expulsion syndrome, Eating disorder, Anorexia, Bulimia, EDNOS, Abnormal
eating, C/S, Chewing and spittingPlain English Summary
Some people have a problematic weight control behav-
iour of chewing their food and spitting it out before
swallowing, or Chew and Spit. We searched all the sci-
entific papers that we could find on Chew and Spit for
information but there were only nine studies and they
could not be relied upon because of poor scientific qual-
ity. However, it seemed likely there was an association
between Chew and Spit and eating disorders like an-
orexia nervosa. Studies of why people Chew and Spit,
how it affects their health, and how to help them are
needed.Background
Chew and Spit (CHSP) is the pathological behaviour of
chewing a food, often of subjectively enjoyable quality as* Correspondence: p.hay@westernsydney.edu.au
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before swallowing as a means to avoid ingesting un-
wanted calories [1]. CHSP is an understudied weight
control method possibly used as a binge eating compen-
satory behaviour employed by individuals with an eating
disorder (ED).
The three most widely recognised ED diagnoses are
Anorexia Nervosa (AN), typically characterised by be-
haviour of extreme calorie restriction, Bulimia Nervosa
(BN) with its attendant behaviour of binging and pur-
ging (BP), and Eating Disorders Not Otherwise Specified
(EDNOS) – including sub-threshold diagnoses of AN
and BN – which has been revised into Unspecified Feed-
ing and Eating Disorders (UFED) and Other Eating and
Feeding Disorders (OSFED) in the DSM-5 [2–4].
Although the behaviour of CHSP is not found in current
diagnostic schemes, it has been identified across the
spectrum of EDs and was present in former diagnostic
criteria such as the DSM-IV [5].le is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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gage in CHSP for a variety of reasons. For example, indi-
viduals undergoing bariatric surgery, those with diabetes,
and athletes adhering to strict dietary guidelines may use
CHSP to ‘taste’ food while adhering to their prescribed
meal plans or eating requirements [6–8]. Many people
also report disordered eating and ED behaviours pre and
post bariatric surgery and it is likely that ED behaviours,
including CHSP, are under reported and not detected
during surgical assessments [7, 9–11]. However, the psy-
chological and physiological effects of CHSP have yet to
be delineated in any population.
The physiological process of preparing to receive food,
called the cephalic response, is linked to metabolic
changes in the body. Some studies involving modified
sham feeding have focused on specific hormones, such
as insulin, obestatin, and ghrelin as part of the cephalic
response [11–17]. However, few studies involving sham
feeding do so in the context of disordered eating [18–21].
Nor do sham-feeding studies focus on behaviour and psy-
chological phenomenology, with specific studies into the
influence of CHSP on metabolic responses being non-
existent [19–25]. Empirical studies into the aetiology, psy-
chological impacts, and physiological outcomes of CHSP
would offer insight into an understanding of such
processes in individuals with broader EDs, diabetes,
or who are prone to post-bariatric-surgery dumping
(the quick passage of food from the stomach to the small
intestine) [18].
Hypothesised outcomes of CHSP may include weight
gain due to accidentally ingesting calories, psychological
and emotional distress (such as shame and guilt), andFig. 1 Search string used for database searchingother physiological sequelae (such as damage to teeth,
stomach ulcers, and hormonal imbalances) [6–9]. In
addition to the possible psychological and physiological
effects of CHSP, social consequences such as social isola-
tion and financial strain (as seen in individuals with BN)
may result, especially if an individual is prone to frequent
CHSP ‘binge’ type episodes [26, 27].
This systematic review aims to examine existing evi-
dence, identify, and critically examine studies that have
investigated the distribution of CHSP behaviour, its rela-
tionship to EDs, and physical and psychosocial conse-
quences. As the literature is sparse, the search and
eligibility criteria were broad. The review also aims to
identify gaps in the knowledge as, to date, little appears
to be known about CHSP within and outside of EDs, in-
cluding its prevalence, distribution, and putative harmful
physical or psychological effects.
Methods
Search strategy and study eligibility criteria
The following electronic databases were searched: Med-
line, PubMed, Web of Science, the Cochrane Library,
CINAHL, EMBASE, PsychInfo and Scopus using the
search strings outlined in Fig. 1. Searches were conducted
using key words and repeated using MeSH categories
where applicable. References of included studies were
manually screened by title. The full text for any potentially
eligible studies was sourced and assessed for eligibility.
Inclusion criteria for studies are listed on Table 1.
Only peer-reviewed studies were considered for inclu-
sion to ensure data integrity and maintain quality. Stud-
ies of non-human participants were excluded as were
Table 1 Inclusion criteria for literature relating to ‘Chew and
Spit’
Sample population Humans only (ED or Non-ED)
Age group Any
Condition Participants must have a ‘lifetime history’ of
CHSP (in conjunction with or without other
ED behavior) and have exhibited the behavior
prior to the study and not solely as part of
another study with modified sham feeding.
The main focus of the study must be centered
on chewing and spitting out of food only,
and not related to the regurgitation of
swallowed food.
Study type & design Any – including but not limited to RCTs,
case studies and case series reports
Outcome measure Assesses or explores some impact
(physiological, social, or psychological)
resulting from CHSP
Setting No restriction
Date of study All studies up to and including January 2016
Publication type &
availability
Peer-reviewed and full-text only
Language English only
Fig. 2 Flow diagram highlighting selection process of included articles [28
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gorized in the DSM-5 as two distinct disorders separate to
CHSP [2]. CHSP is distinctive from rumination, which is
the regurgitation of stomach contents that is either
chewed and re-swallowed, or spat out; and can occur in-
voluntarily – often seen in those with severe purging sub-
type eating disorders as a motivated and habitual
behaviour – or voluntarily [27]. On the other hand, pica
involves the ingestion of non-food items [27]. The defin-
ition of CHSP thus was limited to the conscious chewing
and spitting out of food only without regurgitation of
swallowed food. As commonly seen in eating disorders,
symptoms may overlap. However, studies were excluded if
they did not focus on CHSP specifically or were related to
regurgitation or chewing and spitting non-food items [27].
Two authors (PA and NS) independently screened ti-
tles and abstracts of search results and full-text articles
were retrieved of those studies that had potential to fit
the inclusion criteria (Table 1). The two authors also
assessed full-text articles to confirm that articles met to
eligibility criteria. Disagreements were resolved through
discussion, or referral to a third review author.
A flow diagram in accord with PRISMA guidelines
[28] of the number of identified records is depicted in
Fig. 2.]
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Data regarding CHSP symptomology, prevalence, psycho-
logical, social, or physiological impacts were extracted
from the included studies. Data not directly related to
CHSP were not included in the summary tables.
Quality assessment
Study quality was assessed using a modified version of
the Downs & Black Quality Index [29], as amended by
Ferro and Speechley [30]. The quality index excluded
items specifically related to randomised controlled trials
(RCTs) such as those items assessing randomisation,
dropouts, blinding, and intervention integrity: none of
the included studies were RCTs. The amended version
of the quality index had 15 items, as opposed to the ori-
ginal 27, and dichotomously scored various items as 0
(Unable to determine/No) and 1 (Yes). This resulted in
subscales assessing reporting (7 items), external validity
(3 items), internal validity (4 items), and study power (1
item). The maximum score was 15 with higher scores








Song et al. [34] 1 1
Guarda et al. [32] 1 1
De Zwaan [37] 1 0
McCutcheon & Nolan [39] 1 0
Makhzoumi et al. [36] 1 1
Kovacs et al. [38] 1 1
Durkin et al. [35] 1 1
Mitchell et al. [1] 0 1















Song et al. [34] 0 1 0
Guarda et al. [32] 0 1 0
De Zwaan [37] 0 0 0
McCutcheon & Nolan [39] 0 0 0
Makhzoumi et al. [36] 1 0 0
Kovacs et al. [38] 1 1 0
Durkin et al. [35] 1 0 0
Mitchell et al. [1] 0 0 0
Smith and Ross [33] 0 0 0Results
Of the 320 studies identified, only nine met the eligibility
criteria for inclusion in the systematic review – six
cross-sectional studies, and three case studies. The
Quality Index Scores were modest: of the nine studies,
only two studies scored 10 while all other studies
scored ≤ 9 (Table 2). No study reported response rates,
adjusted for confounding or reported power size/sample
calculation. All were clinical samples and none represen-
tative of the treatment majority. Given the heterogeneity
across studies, data are presented qualitatively. Table 3
summarises the methods of included studies, while the
main findings of each study are summarised below.
Main findings
The nine studies included indicate that CHSP has been
investigated in predominantly ED samples [1, 32–39].
The results below indicate a number of similarities be-
tween individuals with an ED who engage in CHSP.
As shown in Table 3, one cross-sectional study by
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1 1 1 0 0 9
1 1 1 0 0 9
0 0 0 0 0 2
0 0 0 0 0 2
1 1 1 0 0 10
1 1 1 0 0 9
1 1 1 0 0 10
0 0 1 0 0 4
0 0 0 0 0 2
Table 3 Summary of included studies in this review of Chew and Spit behaviour







and other ED related
symptoms
359 Patients (Mean
age = 23.2, SD = 6.6)
diagnosed with EDs using
DSM-IV-TR by a psychiatrist
Cross-Sectional Study. Results
of ED patients who CHSP
were compared to those
who do not CHSP. ED
symptoms compared






EDI-2, FCQ, BSQ, BDI, BAI,
and MOCI
Mind & Mind ED Clinic
presentations between







To evaluate the prevalence
and frequency of CHSP in
trans-diagnostic ED patients
301 Patients (Mean age = 25,
SD = 10) were diagnosed by




of ED patients who CHSP
were compared to those












De Zwaan [37] To present a novel case
report on one patient
19-year-old female with
a history of EDs (AN,
43 kg/15.6 kg/m2).





To present a novel case
report on two patients
Patient 1: 27 year old female
Patient 2: 19 year old female
college student








To characterize CHSP in a large
sample of ED inpatients
treated in a hospital-based
behavioural speciality program.
To investigate associations
between regular CHSP and
personality dimensions, ED and
depression symptomology,
and short-term clinical out-
come variables. To examine
CHSP including the amount of
food typically consumed and
frequency of Loss of Control
(LOC) associated with CHSP
behaviour.
324 Patients (Mean age = 29,
SD = 12.4) were diagnosed by




of ED patients who CHSP
were compared to those





number of nine types of
current and lifetime ED
behaviours were assessed







program for EDs who





To study the prevalence and
association of CHSP in a
series of patients with AN,
BN, and EDNOS
710 adult patients (Mean
age not specified) were
diagnosed according to
the criteria outlined in the
DSM-III-R
Cross-Sectional Study. ED
patients who CHSP were
compared between ED
subtypes (AN, BN, and
EDNOS) and those who did






distortion of body image.




























age = 24.6, IQR = 20.66–31.10)
Cross-Sectional Study.
Patients were classified as
having current CHSP
behaviour or having had
CHSP (at any frequency)
during their lifetime.
EDQ. CHSP behaviour was
assessed was determined by
using 2 general EDQ items.
Patients evaluated at the








A presentation of information
about CHSP in BN patient






Patients (Mean age = 23.9 y,
SD = 5.3) who presented at
an ED clinic prior to the
commencement of the study.
Retrospective analysis.
25 patient files were
retrospectively examined
for indications of CHSP
Files of patients were
retrospectively evaluated and
diagnosed based on the
information present in the
files that corresponds to the
DSM-III BN criteria and who
engaged in CHSP
Files of patients evaluated
at the ED Clinic at the
University of Minnesota





To present a novel case
report on one patient
28-year-old Caucasian obese
female with no previous
history of ED behaviour, but
with a history of treatment
for bipolar disorder.
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logical eating behaviours, higher levels of food craving,
more concerns regarding body shape, and higher levels
of mood and anxiety related symptoms [34]. CHSP was
found to be trans-diagnostic (occurring in AN, BN, and
EDNOS diagnosed individuals), associated with more
pathological compensatory behaviours, and correlated
with greater ED severity [27].
Similarly, a cross-sectional study by Guarda et al. [32]
(N = 310) reported that individuals with EDs engaging in
CHSP (CHSP+) were be younger (mean age 22.6 years,
SD 7.2) than those who did not (CHSP-; mean age
25.6 years, SD 10.5). However, length of illness was not
associated with this finding. Compensatory behaviour
was more prevalent in the CHSP+ group. CHSP was
reported to be trans-diagnostic and was more strongly
correlated with restrictive behaviours than with elevated
purge behaviour (CHSP+/B-). The majority (76 %) of
CHSP+/B+ had a diagnosis of BN and the majority of
those who binged and engaged in CHSP (87 %) also
engaged in purging. There was no significant difference
in in psychometric measures (i.e., BDI, EDI-2, length of
illness, and dieting history) between participants with
CHSP+/B+ and CHSP+/B-. The results of this study
indicated CHSP was positively associated with ED sever-
ity [32].
Makhzoumi et al. [36] reported that, in a cross-
sectional study, 34 % of respondents (N = 324) with
CHSP had binge-like quantities of food (≥ or = 1000 cal-
ories) in their lifetime, and 18 % reported this in the 8
weeks before admission to an ED clinic. Nine out of the
10 individuals engaging in CHSP at the time of the study
reported a subjective sense of loss of control (LOC) at
some point in their lifetime, with a majority of CHSP+
(70 %) reporting LOC even when they CHSP non-binge
quantities. CHSP groups did not differ in demographic
features, clinical indices, or CHSP frequency across ED
diagnostic groups. However individuals who CHSP, were
more likely to have a purging, as opposed to restricting,
diagnosis. Nonetheless, after controlling for behavioural
subtype, individuals with CHSP engaged more frequently
in restrictive eating behaviours, diet pill, laxative abuse,
and over-exercise [36]. Additionally, CHSP+ participants
engaged more frequently in binge eating and appeared
to engage in a wider array of ED behaviours than CHSP-
participants. Finally, CHSP participants had also ex-
hibited greater drive for thinness, body dissatisfaction,
and higher depressive symptomology and neuroticism
(even after controlling for behavioural subtype), and
were more likely to endorse suicide ideation. Makh-
zoumi et al. concluded that CHSP should be assessed
in all ED individuals, as neuroticism is a risk factor
for ED behaviour and is positively correlated with ED
symptoms [36].In a cross-sectional study, Kovacs et al. [38] found that
people with EDNOS (N = 344) and AN (N = 124) who
reported CHSP showed more severe eating behaviour
pathology compared to participants with BN and CHSP
(N = 242). In contrast, participants with BN and CHSP
reported a greater distortion of body image compared to
their AN and EDNOS counterparts. CHSP was trans-
diagnostic and positively correlated with laxative abuse
in individuals with AN. The individuals with EDNOS
who engaged in CHSP appeared to exhibit traits con-
cordant with AN. Subjective overeating appeared to be a
positive predictor of CHSP in the AN group.
Results of a cross-sectional study by Durkin et al. (N =
972) [35] indicated an overall positive association be-
tween being diagnosed with an ED and lifetime CHSP,
with CHSP frequencies ranging from less than or equal
to once a month to several times a day. The majority
(67.9 %) of those who engaged in CHSP at some point
in their lifetimes generally were still currently engaging
in the behaviour at the time of study. The results also in-
dicated that participants who have had a lifetime history
of CHSP were more likely to have been diagnosed with
AN or BN as opposed to EDNOS. However, the authors
did not indicate if CHSP was a risk factor for developing
a clinical ED in the future [35]. Findings of the study in-
dicated that CHSP was not trans-diagnostically present
–unlike in the other cross-sectional studies - but was
more commonly associated with those with an AN or
BN diagnosis as opposed to EDNOS. Younger partici-
pants were more likely than older participants to engage
in CHSP. Furthermore, it was demonstrated that CHSP
was associated with both past and present restrictive be-
haviour and CHSP is usually used as a short-term com-
pensatory behaviour for some individuals with EDs [35].
In a cross-sectional study Mitchell et al. [1] (N = 25)
found 68 % of the 25 participants reported CHSP with
8 % indicating having had CHSP at a minimum fre-
quency of several times a week at some point during
their illness. The authors posited that CHSP is used as a
substitute for binging and purging or other bulimic be-
havioural patterns. In this study CHSP occurred at a low
frequency in women with BN [1]. When comparing indi-
viduals with BN who had low frequency CHSP to those
with high frequency CHSP, there was no significant dif-
ference between these types of participants and a control
group [1].
Of the included studies, three were case reports (De
Zwaan [37], McCutcheon and Nolan [39], and Smith
and Ross [33]) outlining participants’ histories, both in
the context of CHSP and wider ED behaviour. In total,
the case studies report on four females aged between 19
and 28. Similar themes between the reports highlight
that CHSP was used as a weight-control method and
was often associated with negative emotions such as
Aouad et al. Journal of Eating Disorders  (2016) 4:23 Page 8 of 10self-disgust, remorse, and shame, but may have been be
less distressing than binging and purging [33, 37, 39].
Additionally, because of CHSP, individuals appeared to
have concerns over social, financial, and familial issues
[33, 37, 39]. Only one study, by Smith and Ross [33] of-
fered possible explanations for the CHSP behaviour, in-
cluding avoiding feeling deprived, addiction transference,
a stress response, or a deficiency in trace minerals or
vitamins.
Discussion
This systematic review identified nine studies that met
the eligibility criteria [1, 32–39]. Grey literature, clinical
but non-academic sources, and other sources that did
not meet the eligibility criteria were surveyed to generate
plausible hypotheses and mechanisms for describing
pathways and outcomes of CHSP. However, the preva-
lence of CHSP remains unclear due to the paucity of
peer-reviewed academic literature on CHSP and the
available studies being case studies or cross-sectional
studies with small sample sizes that are mostly com-
prised of adult female participants. The psychological,
social, or physiological precursors or outcomes of the
behaviour also remain unclear. Moreover, the Ferro and
Speechley [29] index scores raised concerns about the
quality of studies, with no single study scoring above ten
on a fifteen-point scale. Further to this, none of the
studies made comment on probable resulting referral
bias or the differences in comorbidity dependant on in-
patient or outpatient setting and clinical specialties (see
Table 3 for included study settings). Such referral bias
could have given rise to higher numbers of participants
with specific eating disorders than would sampling
CHSP across the ED spectrum. The quality of eligible
studies was of concern as no RCTs were conducted to
investigate responses to various treatment options for
the disordered behaviour of CHSP. Overall, the included
studies did not provide deep insight into the wider
prevalence and consequences of CHSP.
The included studies reported a wide range of frequency
of CHSP in ED samples ranging from 22 to 100 %. With
the exception of diuretic and laxative misuse, the disor-
dered behaviours of binge eating and dietary restriction
were very common (ranging over 70 %) in people with
lifetime or current CHSP [32, 34, 36, 38]. Both Durkin
et al. [35] and Guarda et al. [32] reported that CHSP ap-
pears to be more common in younger individuals with
eating disorders.
All included studies except for Smith and Ross [33]
focused on the behaviour of CHSP exclusively in ED
individuals. Smith and Ross [33] presented a case study
on CHSP symptomology in a patient who was not diag-
nosed with an ED but who turned spontaneously to the
behaviour during a period of extreme calorie and nutrientdeprivation akin to that experienced during disordered
eating patterns.
Further to this, CHSP may be an indicator of ED
behavioural severity [32]. As ED illness severity increases,
individuals may experiment with more ED behaviours
such as CHSP. CHSP may serve as a way to taste ‘forbid-
den’ or feared food, and it is possible that CHSP ‘binging’
may develop as a substitute for regular binging and pur-
ging even if the associated risks with the behaviour appear
elevated [32, 34, 36, 39].
While the participants in the Mitchell et al., [1] study
were not studied systematically relative to treatment
they received, a review of their charts indicated that
most were able to participate in an outpatient program
for BN and had apparent success (however no follow-up
study was conducted). It appeared that those that en-
gaged in CHSP at high frequencies may eventually cease
or decrease the behaviour with most not using CHSP as
a substitute for purging (laxative or vomiting) but may
rather alternate between the two behaviours [1].
Prior to the DSM-5 [2, 5], CHSP was included under
the EDNOS classification. However, in the DSM-5 CHSP
behaviour has been removed from the definition of
OSFED and UFED (formerly EDNOS) with no ex-
planation or transfer to another ED diagnostic category.
One possible reason for this is that CHSP crosses ED
diagnostic boundaries. Studies included in this systematic
review indicate that CHSP is likely to be a trans-diagnostic
behaviour [34, 36, 38]. Therefore, it is the recommen-
dation of the authors of the present systematic review that
clinicians consider inquiring about CHSP in all people
presenting with an ED (or disordered eating).
This review identified a number of limitations in the
current research centred on CHSP, all of which appeared
to be of modest quality and, one-third of what little
literature was found came from case studies. Only one
case study involved a person without an ED and few
studies undertook an in-depth analysis of the physical,
social, or psychological implications of CHSP, with no
studies deeply investigating physical or social impacts.
None of the studies investigated CHSP in children or as
a precursor to EDs later in life. We found no longitu-
dinal studies and men and children with CHSP were
severely under-represented in study samples. It is likely
that the bias towards female participants was due to the
study samples being based in ED clinics and it is known
men with EDs are less likely to access treatment services
than women [40]. However, it is also indicative of the
relative neglect of men in ED research [40–42].
Longitudinal studies are needed to determine the
prolonged effects of CHSP and the impacts on physiological,
psychological, and social well-being. Such studies would
provide greater insight treatment design for those that en-
gage in CHSP but may not meet full diagnostic ED criteria.
Aouad et al. Journal of Eating Disorders  (2016) 4:23 Page 9 of 10A limitation to this review is that it sourced only
English-language studies. One study in Japanese was
present in the original literature search and there may
have been others if non-English language databases had
been searched. This would potentially have increased
the number of studies and study participants of non-
Caucasian descent.
Another limitation of this systematic review was its
inability to source empirical studies on CHSP practices
in populations without EDs but with specific dietary re-
quirements, such as individuals with diabetes, athletes,
bodybuilders, and bariatric patients. As bariatric surgery
is becoming more commonplace in the treatment of
morbid obesity, it would be relevant to ascertain how
common CHSP is in this population [43]. The impact of
CHSP on weight loss, as well as possible psychological
and medically adverse complications in these groups, is
at this time uncertain. The focus of published studies on
CHSP and its association with EDs rather than in indi-
viduals who exhibit CHSP alone may result in some
‘at-risk’ people not being clinically identified as engaging
in CHSP.
Further and higher quality research into CHSP is
needed to provide greater understanding across several
areas including: gaining insight into CHSP treatment,
along with other more common ED types; bringing relief
and insight for those engaging in CHSP; assisting clini-
cians who seek to treat individuals overcome CHSP be-
haviours; and providing clinicians with clear guidance for
screening and treatment of CHSP [44]. Studies should also
investigate the precursors and outcomes of CHSP not only
in individuals with EDs but also in undiagnosed individ-
uals who engage in CHSP and those who may be at risk of
beginning the behaviour.
Conclusion
This systematic review of CHSP literature revealed no
consensus on the ED typology most closely associated
with CHSP. The small number of poor quality studies
published demonstrates that CHSP is an understudied
topic.
Higher quality studies, including qualitative, quantitative,
mixed-methods, and longitudinal studies, are required to
add depth to clinical, physiological, psychological, and so-
cioeconomic understandings of CHSP and its treatment.
Such studies would assist in determining if there is a com-
mon psychological link between individuals with CHSP
behaviour with and without an ED.
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